Novel Applications of Combination Therapies for Enhanced Productivity and Sustainability
Legal Citation
Summary of the Inventive Concept
The inventive concept leverages the core technology of combination therapies to revolutionize various industries, including agriculture, food processing, renewable energy, water purification, and infrastructure development, by enhancing productivity, reducing waste, and promoting sustainability.
Background and Problem Solved
The original patent disclosed combination therapies for treating progeroid diseases and conditions, cellular aging, and cardiovascular and bone diseases. However, these therapies have untapped potential for application in other fields. The inventive concept addresses the limitations of the original patent by exploring new use cases, thereby unlocking the full potential of these combination therapies.
Detailed Description of the Inventive Concept
The inventive concept involves the administration of a therapeutically effective amount of a farnesyltransferase inhibitor and an mTOR inhibitor to various systems, including agricultural crops, perishable food products, renewable energy sources, water purification systems, and infrastructure materials. This results in enhanced yields, reduced spoilage, optimized energy production, reduced biofouling, and improved material durability, respectively.
Novelty and Inventive Step
The inventive concept's novelty lies in its unexpected application of combination therapies to entirely new fields, solving problems that were not previously considered. The inventive step is the recognition of the potential for these therapies to have a profound impact on productivity and sustainability across multiple industries.
Alternative Embodiments and Variations
Alternative embodiments may include varying the dosages, formulations, or administration methods of the combination therapies, as well as exploring different types of inhibitors or additional active ingredients. Variations may also involve adapting the inventive concept to address specific challenges or requirements within each target industry.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential across multiple industries, including agriculture, food processing, renewable energy, water purification, and infrastructure development. The market for these applications is vast, with potential customers including farmers, food manufacturers, energy producers, municipalities, and construction companies.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical and biotechnology research, with expertise in molecular inhibitor therapies, cellular aging mechanisms, and therapeutic combination strategies
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in molecular biology or pharmacology, familiar with inhibitor mechanisms, combination therapy principles, and cross-disciplinary applications of targeted molecular interventions
Obviousness Rationale
A PHOSITA would recognize that the fundamental mechanism of farnesyltransferase and mTOR inhibitors can be systematically applied beyond medical treatments to address cellular stress and optimization challenges across multiple domains. The source patent establishes the core therapeutic combination, which a skilled practitioner would naturally explore for broader applications given the inhibitors' fundamental cellular interaction properties. The PTD's variations represent predictable extensions of the original combination therapy concept by applying known molecular intervention strategies to different systemic challenges.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,541 |
|---|---|
| Title | Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis |